{
    "version": "https://jsonfeed.org/version/1.1",
    "title": "Harvard Health Posts by T. Salewa Oseni, MD Feed",
    "home_page_url": "https://www.health.harvard.edu/authors/t-salewa-oseni-md",
    "feed_url": "https://www.health.harvard.edu/authors/t-salewa-oseni-md/feed/json",
    "language": "en-US",
    "icon": "https://www.health.harvard.edu/img/logos/hhp-logo-mark-lg.jpg",
    "items": [{
            "id": "https://www.health.harvard.edu/blog/can-some-postmenopausal-women-with-breast-cancer-skip-chemotherapy-2021041522344",
            "title": "Can some postmenopausal women with breast cancer skip chemotherapy?",
            "url": "https://www.health.harvard.edu/blog/can-some-postmenopausal-women-with-breast-cancer-skip-chemotherapy-2021041522344",
            "content_html": "Advances in breast cancer research have led to more personalized treatments, based on subtyping and more sophisticated testing. A risk assessment test can predict that some women do not need chemotherapy but will benefit from hormone therapy, and who might benefit more from both treatments.",
            "summary": "Advances in breast cancer research have led to more personalized treatments, based on subtyping and more sophisticated testing. A risk assessment test can predict that some women do not need chemotherapy but will benefit from hormone therapy, and who might benefit more from both treatments.",
            "date_published": "2021-04-15T00:00:00-04:00",
            "date_modified": "2021-04-15T00:00:00-04:00",
                        "authors": [                { "name": "T. Salewa Oseni, MD" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/10480/conversions/GettyImages-1033239842-thumb.jpg",

            "tags": [ "Cancer","Medical Research","Women's Health" ]
        }        
    ]
}